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Abstract 
Fetal Alcohol Spectrum Disorder (FASD) is the leading preventable cause of developmental 
delay worldwide.  Early diagnosis and intervention are vital to the prevention of secondary 
disabilities for those with FASD.  Current diagnostic guidelines fail to identify the many physical 
malformations associated with prenatal alcohol exposure and recommendations for diagnostic 
differentials vary between guidelines.  A critical appraisal of the literature and review of current 
guidelines was conducted to create an evidence-based physical anomaly checklist and 
differential diagnostic table.  The critical appraisal consisted of 27 articles and resulted in 85 
physical anomalies associated with prenatal alcohol exposure.  The review of current guidelines 
resulted in five guidelines and four supportive articles that identified 20 different genetic 
disorder differentials and four exposure related differentials.  A Plan-Do-Study-Act (PDSA) 
quality improvement model was used to implement education on the reference tools and 
encourage practice implementation in a North American FASD diagnostic team.  All providers 
directly participating in the diagnosis of FASDs must be aware of the many physical anomalies 
associated with prenatal alcohol exposure and should have a working knowledge of potential 
differential diagnoses.  The physical anomaly checklist and differential diagnoses tables help to 
provide this information in a clinically practical way.
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Physical Assessment of Children with Fetal Alcohol Spectrum Disorder 
Though the harmful effects of alcohol exposure in utero have been alluded to since early 
Greek and Roman history, the classic triad of symptoms now associated with Fetal Alcohol 
Syndrome (FAS) was first described by Jones and Smith in 1973.  FAS is characterized by three 
main attribute groups; facial dysmorphology, growth retardation, and central nervous system 
deficits (Murthy, Kudlur, George, & Mathew, 2009).  Since these early studies, the effects of 
alcohol consumption during pregnancy have been extensively studied using animal models and 
case reports from human subjects.  While FAS is considered the most severe presentation found 
in those with prenatal alcohol exposure, the teratogenic effects on the embryo and fetus are now 
known to exist on a continuum (Davis, Desrocher, & Moore, 2011).  The severity of the effects 
of exposure to alcohol in pregnancy vary based on genetics, timing during the gestational period, 
the level of alcohol exposure, and the overall nutrition status of the mother (Warren, Hewitt, & 
Thomas, 2011).  Symptoms range from subtle neurological and behavioral dysfunction to the 
most severe deficits found in FAS.  
Fetal alcohol spectrum disorder (FASD) is the current term used to describe the range of 
symptoms that may result from prenatal alcohol exposure.  While FASD is not a clinical 
diagnosis, it is used as an umbrella term to incorporate all possible outcomes of prenatal alcohol 
exposure.  FAS, partial fetal alcohol syndrome, static encephalopathy, neurobehavioral disorder, 
and alcohol related birth defects (ARBDs) are all on the fetal alcohol spectrum (Davis et al., 
2011).  The presentation of these conditions varies from severe growth restriction, intellectual 
disability, and classic dysmorphic facial features to normal growth and intellectual ability. 
(Chudley et al., 2005).  The complexity of the diagnosis requires an interdisciplinary team 
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approach to provide a comprehensive assessment and appropriate recommendations for 
intervention and follow-up (Murthy et al., 2009).  
Background and Literature Review 
Prevalence  
FASD is the leading cause of developmental delay worldwide and foremost preventable 
cause of neurobehavioral impairment (Murthy et al., 2009; Davis et al., 2011).  According to the 
Centers for Disease Control Prevention (CDC), the true prevalence of FASD is unknown in the 
United States.  The estimated prevalence of full FAS is 0.2 to 1.5 per 1,000 live births in the 
United States (CDC, 2014).  May et al. (2009) estimated the prevalence of FAS  in mixed-racial 
and socioeconomic populations in the United States to be at least 2 to 7 per 1,000 with FASD 
rates as high as 2-5% of elementary school age children.  May et al. (2009) further report that 
undiagnosed cases of FASD result in low prevalence estimates and promote school based 
assessments as a means of identifying true prevalence in the elementary population.  In 2014 
May et al. completed an updated study using in school screening of first graders in a Midwestern 
U.S. city and found significantly higher prevalence rates of FASD.  Rates of FAS ranged from 
six to nine per 1000 children, PFAS from 11 to 17 per 1000 children, and other FASD 24 to 48 
per 1000 children.  
Prevalence in Alaska.  The most recent data from the FAS Surveillance Project in 
Alaska found the prevalence of FAS to be 1.5 per 1,000 live births of children born from 1995-
1999, or approximately 15 children each year in Alaska are born with FAS. The estimated 
number of children reported to the Alaska Birth defects Registry as being effected by prenatal 
alcohol exposure is 163 children per year or 16.3 per 1,000 live births (Alaska Department of 
Health and Human Services, 2012).  Alaska has the highest rate of FAS in the nation among 
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states that track data on birth defects; as many as 180 children per year have been reported to the 
Alaska Birth Defects Registry as having a suspected fetal alcohol spectrum disorder (Alaska 
Department of Health and Human Services, 2010). 
Economic Burden 
The lifetime cost of caring for an individual with FAS was estimated at two million 
dollars in 2002.  The annual cost of FAS alone was estimated at four billion U.S. dollars in 2004 
(CDC, 2014).  Thus, FAS and FASD represent a major public health concern in the United 
States.  While the direct costs of FAS may be accounted for, it is difficult to assess the true 
impact of the disorder on the individual, family, and society (Murthy et al., 2009).  
Unemployment, mental health problems, criminal activity, inappropriate sexual behavior, and 
school disruption are all secondary disabilities that may result from FASD without intervention 
to minimize the impact of the disorder (Chudley et al., 2005).  
Importance of Early Diagnosis 
Early diagnosis is vital for improved developmental outcomes and prevention of future 
cases of FASD within the individual family. When early intervention occurs, parents may be 
counseled and receive information on prevention (Sanctis, Memo, Pichini, Tarani, & Vagnarelli, 
2011).  In addition to prevention, early diagnosis can benefit the child already affected by 
prenatal alcohol exposure. A study in 2004 examined the life histories of 415 individuals with 
known FAS and fetal alcohol effects (FAE) and found that the number one predictor of adverse 
life events was a lack of early diagnosis. The study found that the longer individuals went 
without a diagnosis, the greater the chance they had of having adverse life events. Both early 
diagnosis and a stable home environment were shown to be predictors of better outcomes and 
less adverse life events. The adverse life events that were studied included: inappropriate sexual 
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behavior, disrupted school experience, trouble with the law, confinement, and alcohol and drug 
problems (Streissguth, Booksein, Barr, Sampson, & O’Malley, 2004).   
While early diagnosis is key to preventing secondary disabilities in children with prenatal 
alcohol exposure, to provide the best care to these children, the diagnosis must be accurate. 
When an accurate diagnosis is given FASD diagnostic teams recommend interventions that are 
patient and family specific. Once key deficits are identified by the interdisciplinary diagnostic 
team, the patient and family are given recommendations for therapies and follow-up care. 
According to Astley (2014) a survey of patients from the past twenty years that were given a 
diagnosis of an FASD using the 4-digit diagnostic code reported that the diagnosis opened doors 
to interventions and services they needed (Astley, 2014). Thus, while diagnosis and intervention 
seem to have a great benefit to the individual and their family; FASD diagnostic teams must 
ensure that FAS or other FASD remain a diagnosis of exclusion (Astley, 2004).  
Diagnostic Challenges 
 FASD may be challenging to diagnose for several reasons.  First obtaining a reliable 
history of prenatal alcohol use can be challenging; the birth mother may be reluctant to admit 
alcohol use during pregnancy.  Furthermore, receiving an accurate account of the amount of 
alcohol consumption and timing during pregnancy may also be difficult or impossible to elicit.  
The pregnancy history may be unknown in cases of adoption and foster care which may result in 
difficulty determining a diagnosis and excluding other differentials.  The apparent lack of the 
characteristic facial features associated with FAS may also lead to a misdiagnosis (Bertrand et 
al., 2004).   
  Providers also face the challenge of distinguishing FASD from other prenatal exposures 
and genetic disorders.  The lack of consistent terminology has complicated the diagnostic process 
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since the characteristics of FAS were first described in 1973 (Warren, Hewitt, & Thomas, 2011). 
While there are guidelines for the diagnosis of FASD, many of the current guidelines do not 
adequately account for other genetic diseases (Hoyme et al., 2005).  Hoyme and associates 
produced a clarification of the Institute of Medicine (IOM) guidelines for diagnosis and 
emphasized the importance of creating a guideline that would minimize the rates of false 
positives and false negatives and precisely define the diagnostic categories.  While receiving a 
diagnosis is important for early intervention, the consequences of misdiagnosis are many and are 
often not highlighted in the literature.  Misdiagnosis may lead to false stigmatization of the 
mother, inaccurate labeling and inappropriate treatment and referral, which may ultimately cause 
diagnostic studies to be terminated prematurely resulting in the true cause of the disability being 
overlooked (Hoyme et al., 2005).  Furthermore, misdiagnosis results in inaccurate prevalence 
data and may ultimately lead to inadequate funding for social and health services to those with 
FASD (Chudley et al., 2005).  
Current Diagnostic Guidelines  
  A preliminary examination of current guidelines highlights the inconstancies between 
guidelines and demonstrates the lack of specific physical assessment recommendations and 
differential diagnoses tables.  The CDC guidelines, 4-digit diagnostic code, clarification of the 
IOM criteria, and the Canadian guidelines for diagnosis are explored in further detail. These 
guidelines demonstrate some of the current gaps in the diagnostic process and support the need 
for further research and review of the guidelines.  
The CDC guidelines for diagnosis and referral.  Bertrand et al. (2004) developed a 
guideline for diagnosis and referral of FAS as part of the CDC task force.  This guideline utilizes 
four criteria for FAS: facial dysmorphia, growth problems, central nervous system abnormalities, 
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and maternal alcohol exposure.  The individual must exhibit all three facial characteristics: 
smooth philtrum (University of Washington Lip-Philtrum Guide rank 4 or 5), thin vermillion 
border (University of Washington Lip-Philtrum Guide rank 4 or 5), and small palpebral fissures 
(at or below the 10th percentile).   
Growth problems are defined as prenatal or postnatal height or weight or both below the 
10th percentile (adjusted for age, sex, gestational age, and race).  Central nervous system 
abnormalities are defined as structural (head circumference at or below the 10th percentile 
adjusted for age and sex, clinically significant brain abnormalities observed with imaging), 
neurologic (neurologic problems not associated with post-natal insult or fever), functional 
(performance substantially below expected for an individual’s age, schooling or circumstances 
defined as global cognitive or intellectual deficits in multiple domains with performance below 
the 3rd percentile or two standard deviations below the mean for standardized testing), or (deficits 
below the 16th percentile/one standard deviation below the mean in at least three of the following 
areas: cognitive or development deficits, executive function deficits, motor function delays, 
problems with attention or hyperactivity, social skills, other sensory problems, language 
problems, or memory deficits).  Maternal alcohol exposure may be confirmed directly by the 
mother or from a reliable adult source, or it may be classified as unknown prenatal exposure.  
The first three components are required for a diagnosis with maternal alcohol classified as 
confirmed or unknown (Bertrand et al., 2004).  
 The CDC guideline highlights several prenatal exposure syndromes and genetic disorders 
that share some of the clinical manifestations of FAS. A table provides a list of  syndromes with 
similar features: Cornelia de Lange syndrome, Floating-harbor syndrome, Geleophysic dysplasia, 
Opitz syndrome, Toluene embryopathy, Miller-Dieker (Lissencephaly) syndrome, Fetal 
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Valproate syndrome, Campomelic dysplasia, DiGeorge sequence, Dubowitz syndrome, 
Duplication 10q sequence, Duplication 15q sequence, FG syndrome, Maternal phenylketonuria 
(PKU) fetal effects, Oculodentodigital syndrome, Trisomy 18 syndrome, and Velocardiofacial 
syndrome.  A second table provides differentiating characteristics for the following genetic 
disorders: Aarskog syndrome, Williams syndrome, Noonan’s syndrome, Dubowitz syndrome, 
Brachmann-DeLange syndrome, Toluene embryopathy, Fetal Hydantoin syndrome, Fetal 
Valproate syndrome, and Maternal PKU fetal effects (Bertrand et al., 2004).  
 Bertrand and associates (2004) provide guidance on differential diagnoses and mention 
ARBDs and ARNDs, but do not provide clear guidelines for these diagnoses because there was 
not agreement on diagnostic criteria.  The CDC guideline does not provide any information on 
malformations associated with prenatal alcohol consumption.  Though the guideline recommends 
that a thorough physical exam is conducted during the diagnostic process, a clear and concise 
recommendation for the physical exam is not defined.  
The 4-digit diagnostic code 3rd edition.  In 2004, the third edition of the 4-digit 
diagnostic code was released with updates based on recommendations of Canadian and U.S. 
guidelines.  Like the CDC, Institute of Medicine (IOM), and Canadian guidelines the 4-digit 
diagnostic code recommends a multidisciplinary diagnostic team consisting of professionals 
from (medicine, psychology, speech-language pathology, occupational therapy, as well as other 
disciplines).  However unlike other guidelines, the 4-digit diagnostic code outlines a diagnostic 
process that enables providers to classify the severity of the clinical manifestations of an FASD 
with a 4 point ranking system.  A ranking of 4 is considered the most severe and a ranking of 1 is 
the complete absence of the clinical feature.  The manifestations ranked according to symptoms 
include growth, facial phenotype, central nervous system (CNS) effects and alcohol exposure.  
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The facial phenotype is calculated with the use of computerized software that measures and 
quantifies facial features associated with FAS (Astley, 2004). 
 Growth deficiency is given a rank of 4 when there is severe growth restriction classified 
as height and weight less than the 3rd percentile.  A Growth rank of 3 occurs when either the 
height or the weight is less than the 3rd percentile, and the other measure is greater than the 3rd 
percentile.  A rank of 2 is considered mild when height or weight is greater than the 3rd percentile 
but less than or equal to the 10th percentile or when both height and weight are between the 3rd 
and 10th percentile.  Growth is considered normal when both height and weight are greater than 
the 10th percentile.  
The facial features associated with FAS (palpebral fissures, upper lip, and philtrum) are 
measured using facial photographic analysis software.  A rank of 4 is a severe presentation and 
occurs when the palpebral fissure length is less than or equal to two standard deviations (SDs) 
below the norm and when the lip and philtrum is ranked at 4 or 5.  A rank of 2 or 3 is given when 
a combination of severe and moderate measures are found and can be determined to be either 2 
or 3 based on table of measurement combinations.  A rank of 1 occurs when there is very little 
evidence of the facial features and a combination of close to normal or normal measurements are 
determined with the software.  
The CNS ranking of 4 occurs when there are structural or neurological abnormalities and 
is termed static encephalopathy.  Findings that confirm a rank of 4 include: occipital frontal 
circumference (OFC) two or more standard deviations below the norm and/or there are 
significant abnormalities in brain structure of presumed prenatal origin and/or hard neurological 
findings likely of prenatal origin.  A CNS rank of 3 occurs when there is significant impairment 
in three or more domains of brain function (cognition, memory, motor, language, neurological 
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soft signs, etc.).  A rank of 2 or mild dysfunction is given when there is evidence of delay or 
dysfunction but there is not enough evidence to allow a rank of 3 to be given.  Finally, a rank of 
1 is given when there is no evidence of delay or dysfunction to represent CNS damage.  
The final component of the diagnosis is the overall ranking of prenatal alcohol exposure. 
Alcohol exposure receives a ranking of 4 and is considered high risk when there is confirmed 
alcohol use during pregnancy consistent with high peak blood alcohol concentrations at least 
weekly early in pregnancy.  Alcohol exposure is given a rank of 3 if there is confirmed alcohol 
exposure that is less than rank 4 or the level is unknown.  A rank of 2 is given when the use of 
alcohol during pregnancy is unknown.  A rank of 1 is given when alcohol use during pregnancy 
is confirmed to be completely absent from conception to birth (Astley, 2004). 
 While the 4-digit diagnostic code does create clear criteria for the diagnosis of FASD 
across the spectrum and provides a standardized method of measuring facial dysmorphology, the 
diagnostic guide does not provide any type of template for the physical exam.  Astley (2004) 
does reference other syndromes that share symptoms with FAS including: Fetal Hydantoin 
syndrome, Maternal PKU fetal effects, and Fetal Valproate syndrome.  However, this is not a 
complete list of pertinent syndromes nor is there an outline of distinguishing features that would 
help to rule out other differential diagnoses.  The guideline can be applied once other diagnoses 
have been ruled out and FASD is suspected.  Without a clearly defined physical exam and table 
with similar syndromes, making a clear diagnosis can be challenging for the medical provider if 
the 4-digit diagnostic code is used exclusively.  
Clarification of the IOM criteria.  Hoyme et al. (2005) proposed a clarification of the 
1996 IOM guidelines for diagnosis for FASD.  First the guideline recommends an interdisplinary 
team approach to the diagnosis of a FASD.  The diagnosis of full FAS requires: confirmed 
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maternal alcohol exposure, evidence of greater than or equal to two of the following facial 
abnormalities (short palpebral fissures less than or equal to the 10th percentile), thin vermilion 
border of the upper lip (score 4 or 5 with the lip/philtrum guide), smooth philtrum (score 4 or 5 
with the lip/philtrum guide), evidence of prenatal or postnatal growth restriction (height or 
weight less than or equal to the 10th percentile using corrected racial norms if possible, evidence 
of deficient brain growth or abnormal morphogenesis, including greater than or equal to one of 
the following (head circumference less than or equal to the 10th percentile, or structural brain 
abnormalities).  FAS without confirmed maternal alcohol exposure is based on all the same 
criteria without confirmed history of prenatal alcohol use.  
 Partial FAS with confirmed maternal alcohol exposure requires confirmed alcohol use 
during pregnancy. There must also be evidence of a characteristic pattern of minor facial 
abnormalities including two or greater of the following: short palpebral fissures (less than or 
equal to the 10th percentile), thin vermillion border of the upper lip (score 4 or 5 with the 
lip/philtrum guide), one of the following:  evidence of prenatal or postnatal growth restriction 
less than or equal to the 10th percentile, evidence of deficient brain growth or abnormal 
morphogenesis including one or more of the following: structural brain abnormalities, head 
circumference less than or equal to the 10th percentile.  There must also be evidence of a pattern 
of behavior or cognitive function that is not consistent with developmental norms.  These 
aberrations may include difficulties with complex tasks (problem solving, metacognition, 
arithmetic, judgment, planning, or abstract thought), receptive or expressive language deficits, 
and abnormal behaviors (emotional lability, motor dysfunction, poor academic performance, or 
difficulties with social interaction).  Partial FAS without confirmed maternal alcohol exposure 
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includes the above criteria without recorded history of prenatal alcohol consumption (Hoyme et 
al., 2005). 
 The diagnosis of an alcohol-related birth defect (ARBD) requires confirmed maternal 
alcohol exposure.  There must be evidence of two or greater minor facial abnormalities including 
short palpebral fissures (less than the 10th percentile), thin vermilion border of the upper lip 
(score 4 or 5 with the lip/philtrum guide), or smooth philtrum (score 4 or 5 with the lip/philtrum 
guide).  There must also be congenital structural defects greater than or equal to one of the 
following: atrial septal defects, aberrant great vessels, ventricular septal defects, conotruncal 
heart defects, radioulnar synostosis, vertebral segmentation defects, large joint contractures, 
scoliosis, aplastic/hypoplastic/dysplastic, horseshoe kidneys /ureteral duplications, strabismus, 
ptosis, retinal vascular anomalies, optic nerve hypoplasia, conductive hearing loss, or 
neurosensory hearing loss.  If minor anomalies are present, then there must be two or greater of 
the following: hypoplastic nails, short fifth digits, clinodactyly of fifth fingers, pectus 
carinatum/excavatum, camptodactyly, “hockey stick” palmar creases, refractive errors, or 
“railroad track” ears (p. 44).  
 The diagnosis of alcohol-related neurodevelopment disorder (ARND) must have 
confirmed maternal alcohol exposure.  There must be one or more of the following:  structural 
brain abnormalities, or head circumference less than or equal to the 10th percentile.  Behavioral 
or cognitive abnormalities such as those described for the diagnosis of partial FAS must also be 
present. 
 In the footnote of the diagnostic criteria, the authors conclude that first genetic and 
medical assessment must rule out other genetic or malformation syndromes (Hoyme et al., 2005). 
Thus, FAS, partial FAS, ARBD, and ARND remain a diagnosis of exclusion.  The genetic 
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syndromes with similar manifestations as FAS discussed by Hoyme et al. (2005) include 
Williams syndrome, Blepharophimosis syndrome, Dubowitz syndrome, Cornelia de Lange 
syndrome, and Velocardiofacial syndrome.  Though the authors report that this is not an 
exhaustive list, it elucidates the need to rule out other genetic conditions. 
  Although the guideline clarification of the IOM criteria does help to define the diagnostic 
parameters of FASD, it does not provide a specific recommendation for the physical exam 
portion of the diagnostic process.  The ARBDs mentioned in the diagnostic criteria do identify 
malformations that are associated with the condition, but a clear recommendation or template 
would make the guideline more clinically practical.  The discussion of other genetic conditions 
with similar presentations also adds clarity to the diagnostic process, but a more complete list 
and a table with distinguishing features would streamline clinical practice and facilitate 
educating providers about potential alternative diagnoses.  
  The Canadian guidelines for diagnosis.  Chudley et al. (2005) created guidelines for 
Canada’s public health agency by combining, IOM recommendations, the 4-digit diagnostic 
code, and recommendations from expert panels.  A multidisciplinary team consisting of a case 
manager, a medical provider trained in FASD diagnosis, a psychologist, an occupational 
therapist, and a speech-language pathologist is recommended for the diagnosis of an FASD.  
Additional members of the care team may include geneticists, dysmorphologists, 
neuropsychologists, family therapists, childcare workers, addiction counselors, and cultural 
interpreters.  
 The physical abnormalities associated with prenatal alcohol consumption include: atrial 
septal defects, ventricular septal defects, aberrant great vessels, tetralogy of the Fallot, 
hypoplastic nails, shortened fifth digits, radioulnar synostosis, flexion contractures, 
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camptodactyly, clinodactyly, pectus excavatum and carinatum, Klippel-Feil syndrome, 
hemivertebrae, scoliosis, aplastic, dysplastic, hypoplastic kidneys, horseshoe kidneys, ureteral 
duplications, hydronephrosis, refractive problems, strabismus, retinal vascular anomalies, 
conductive hearing loss, and neurosensory hearing loss.  Though many other malformations have 
been found in patients with FAS, the etiologic nature of those abnormalities remains uncertain. 
The physical exam should also look for anomalies such as cleft palate, high arched palate, poorly 
aligned teeth or abnormal teeth, hypertelorism, micrognathia, abnormal hair patterns, skin 
lesions, and abnormal palmar creases to aid in the exclusion of other genetic disorders (Chudley 
et al., 2005). 
 ARNDs can be defined by evidence of physical abnormalities such as decreased cranial 
size at birth, structural brain abnormalities (microcephaly, partial or complete agenesis of the 
corpus callosum, cerebellar hypoplasia), neurological hard or soft signs (impaired fine motor 
skills, poor tandem gait, poor eye-hand coordination, or other neurological signs).  ARNDs can 
also be identified as a pattern of cognitive or behavioral abnormalities: learning disabilities, poor 
school performance, lack of impulse control, social problems, deficits in higher level receptive or 
expressive language, decreased ability for abstract thought or metacognition, difficulty with 
math, memory problems, poor attention span, and problems with judgment (Chudley et al., 
2005). 
 The genetic syndromes listed in the Canadian guidelines include Aarskog syndrome, 
Cornelia de Lange syndrome, Dubowitz syndrome, fetal anticonvulsant syndrome, maternal 
phenylketonuria fetal effects, Noonan syndrome, Toluene embryopathy, Williams syndrome, and 
chromosome deletion and duplication syndromes.  The guideline does provide a table that lists 
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the similar features of the condition and the distinguishing features that differentiate the 
syndromes from an FASD (Chudley et al. 2005). 
 The combination of the IOM criteria and the 4-digit diagnostic code with 
recommendations for the physical exam and pertinent genetic differentials helps to address many 
of the short-comings of other diagnostic guidelines.  While Chudley et al. (2005) do improve the 
clinical practicality of the diagnostic process, their recommendations are made for Canada and 
there is not an equivalent guideline in the United States.  There has also been a great deal of 
research published in the last 11 years regarding the malformations associated with prenatal 
alcohol exposure.  A comprehensive physical anomaly checklist based on current research would 
improve diagnostic accuracy for the United States FASD diagnostic teams. 
Problem Statement 
Nurse practitioners in a North American interdisciplinary FASD diagnostic team 
expressed concerns about the consistency of their current practice. Although all team members 
complete the University of Washington FASD 4-digit diagnostic code training, the nurse 
practitioners who provide the medical evaluation for each case reported that a lack of guidance 
on associated physical anomalies and a lack of guidance on appropriate differential diagnoses 
complicated their diagnostic process.  During two observed team meetings some team providers 
observed malformations that are known to occur with prenatal alcohol exposure but were unsure 
if these anomalies were related to the prenatal alcohol exposure.  During these meetings 
providers also expressed concerns of not knowing when to refer a child to a geneticist for 
evaluation for a possible genetic condition.  These observations and concerns voiced from the 
FASD medical team providers lead to the purpose and goals of this project. 
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While the diagnostic process for identifying children with FASD has improved since the 
first descriptions of FAS were identified in the literature, there are gaps in the evaluation process.  
A clear guideline for the physical examination of children with FASD is not available.  Though 
many associated malformations have been identified in the literature, a concise way of 
documenting the assessment of those conditions is not included in current guidelines.  There are 
several genetic conditions and other prenatal exposure syndromes that have similar presentations 
as FASD and must be considered in the diagnostic process.  A physical anomaly checklist that 
includes pertinent malformations would help to standardize the clinical exam.  Additionally a 
reference table summarizing the distinguishing features would help to ensure that appropriate 
differential diagnoses are evaluated and excluded based on evidence from the literature.  
Purpose 
The purpose of this project was to create clinical reference tools to help standardize the 
physical exam for medical evaluation of FASD.  A checklist that incorporates the physical 
anomalies associated with prenatal alcohol exposure will help ensure that the physical exams 
conducted by the team are systematic and evidence-based.  The checklist will also be used to 
help educate future FASD team medical providers.  A table of differential diagnoses with 
distinguishing physical features that differentiate the disorder from an FASD was compiled 
based on the most current guidelines.  Ultimately the goal of this practice improvement project is 
to empower providers to assess patients in a systematic, evidenced-based manner and continue to 
build and improve their clinical practice based on the evidence. 
Project Goals 
1.  Determine what physical malformations are associated with prenatal alcohol exposure and 
should be considered during the physical exam. 
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2.  Determine the genetic disorders that current guidelines suggest should be considered during 
the FASD diagnostic process. 
3.  Develop a physical anomaly checklist and differential diagnosis table based on findings. 
4.  Increase provider awareness of the physical anomalies associated with prenatal alcohol 
exposure. 
5.  Increase provider awareness of the appropriate differential diagnoses for FASD 
Framework 
 In the 1920s Walter Shewhart developed the Plan-Do-Study-Act (PDSA) cycle and a 
means to facilitate planning and organizing quality and performance improvement measures 
(Ransom, Joshi, Nash, & Ransom, 2008).  During the plan phase of the cycle goals for the cycle 
are determined, predictions or questions are made, and the plan for carrying out the cycle is 
defined.  The do phase often consists of staff education, carrying out the plan on a small scale, 
documenting problems and unexpected observations, and analyzing the data.  The study phase 
occurs when the effect of the change is determined and the level of successfully meeting the goal 
is defined, the changes that need to be made are defined, and lessons gleaned from the phase are 
summarized. Finally the Act phase occurs when the identified changes are made and it is 
determined if the same plan should be repeated with changes or if it is necessary to make a new 
plan, and additional PDSA cycles are conducted until the project goals are met (Ransom et al., 
2008).  
 Marcellus, Harrison, and MacKinnon (2012) applied the PDSA cycle to a quality 
improvement project aimed at the implementation of a guideline into clinical practice.  Methods 
employed in this clinical practice improvement project will serve as a guide to the practical 
application of the PDSA cycle for the FASD project.  
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Method 
Design 
 A critical appraisal of the literature and a review of current guidelines was utilized for the 
practice improvement method for this project.  Findings from the review and critical appraisal 
were introduced to an FASD team to stimulate practice change using a quality improvement 
approach.  The PDSA cycle was used to guide the project design and implementation of a 
physical anomaly checklist and differential diagnosis table into a North American FASD 
diagnostic team’s practice.  The aim of using PDSA as a framework was to encourage team 
providers to actively participate in the design and implementation process to create permanent 
evidenced-based changes that will be truly useful within the practice context.  
PDSA Cycle  
The goals for the initial PDSA cycle included: increasing provider awareness, developing 
clinical reference tools based on the literature, providing education to the team providers, and 
making changes based on feedback from team providers.  This PDSA cycle will serve as a 
starting point of a continuous practice improvement process that the FASD team may continue 
until all the team goals are met. Table 1 provides an outline of how the PDSA cycle was applied 
to this practice improvement project.  Further explanation of the critical appraisal procedures and 
findings, guideline review process and findings, and the construction of the clinical reference 
tools will be described in greater depth following the table.  The implementation process and 
evaluation process will follow the method section and complete the entire PDSA cycle for this 
project.  
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Table 1 
PDSA Cycle applied to the medical evaluation of FASD 
 
Setting Aims: What is the project trying to 
accomplish? 
 Increase provider awareness of the 
physical anomalies associated with 
prenatal alcohol exposure. 
 
 Increase provider awareness of 
appropriate differential diagnoses for 
FASD. 
Establish Measures and Indicators: Is the 
change an improvement? 
 Provider feedback taken from the 
post-implementation survey following 
team education.  
PDSA cycle 1  
Plan: 
 Attend two team meetings and discuss 
concerns about current practice with 
team director 
 Conduct a critical appraisal of the 
literature 
 Review current guidelines 
Study: 
 Team discussion regarding formatting 
changes to the table and checklist 
following education presentation 
 Post-implementation survey findings 
Do: 
 Construct physical anomaly checklist 
 Construct differential diagnoses table 
 Design group education PowerPoint 
presentations 
 Present education, critical appraisal 
grids, physical anomaly checklist, and 
differential diagnoses table to FASD 
diagnostic team 
Act: 
 Edit physical anomaly checklist 
 Send edited checklist to FASD 
diagnostic team director for 
distribution to the team 
 Team  encouraged to continue to 
modify the table and checklist based 
on new research 
 
Critical appraisal procedures.  A critical appraisal of the literature was performed in 
order to answer the research questions and identify evidence based recommendations for the 
physical assessment of children with FASD.  Recommendations for critical appraisal and 
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application of evidenced-based practice were based on methods described by Melnyk and 
Fineout-Overholt (2011) and Dearholt and Dang (2012).  The goals of a critical appraisal are to 
address the study’s validity, reliability, and applicability to ensure that the best evidence is used 
to make practice changes.  A hierarchy of evidence classification was applied to each article so 
that the strength of the evidence would be clearly evident in the critical appraisal grid (See 
Appendix E).  According to this hierarchy articles range from level I evidence being the 
strongest evidence to level V being the weakest level of evidence (Dearholt & Dang, 2012).  
Evidence that is gathered from well-designed experimental studies, randomized control 
trials, and systematic reviews or meta-analysis of randomized controlled trials (RCTs) are 
considered level I evidence.  Level II research consists of well-designed quasi-experimental 
studies, systematic reviews of RCTs and quasi-experimental studies, or systematic reviews of 
quasi-experimental studies only with or without meta-analysis. Non-experimental studies, 
systematic reviews of a combination of RCTs, quasi-experimental and non-experimental, or 
systematic reviews of non-experimental studies only with or without meta-analysis are 
considered level III evidence.  Level IV evidence is generated by works of respected authorities, 
nationally recognized expert committees and includes clinical practice guidelines and works 
from consensus panels.  Literature reviews that are not systematic, quality improvement projects, 
case reports, and opinion from nationally recognized experts are all considered level V evidence 
(Dearholt & Dang, 2012). 
Search parameters.  A search of the literature was conducted utilizing Cochrane 
Library, CINAHL, PubMed, Dynamed, Web of Science, and Google Scholar via the University 
of Alaska’s consortium library in collaboration with the medical librarian.  Selection criteria for 
the studies included:  peer-reviewed, English language, related to human subjects, and 
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publication between 2004 and 2015.  Studies were excluded if they were qualitative, not in 
English, or were not relevant to the research question.  The current edition of the diagnostic 
guideline used by the FASD diagnostic team was published in 2004.  The studies selected for 
this project were published in 2004 to 2015.  This will ensure that the physical assessment 
checklist reflects both research that is contemporary with the guideline as well as updated 
research. Articles selected from Google Scholar were screened by the principal investigator to 
ensure that the selection criteria were met as this search engine does not have a way to include 
search parameters.  The medical librarian strongly recommended including Google Scholar as a 
search engine as traditional indexed databases may miss key articles.  
Critical appraisal findings.  Six medical databases were used to identify pertinent 
articles for the critical appraisal of the literature.  The search terms used for each database were 
selected with collaboration from the University of Alaska Anchorage medical librarian. 
Differences in search terms were based on how the key words were cataloged in each database. 
An initial search using the Cochrane Library search term fetal alcohol spectrum disorder and 
fetal alcohol syndrome yielded one result and three results.  None of the articles in the Cochrane 
Library addressed the research question.  The search terms used in CINAHL were fetal alcohol 
syndrome and abnormalities initially yielded six articles in English that used human subjects. 
Further review of the abstracts resulted in one article that met the search criteria. Dynamed, an 
evidence point of care search engine, yielded one guideline fetal alcohol spectrum disorder as a 
search term.  The Web of Science database initially resulted in 1,424 articles using the search 
term fetal alcohol spectrum disorder. Further review of the each abstract resulted in 84 pertinent 
articles.  However, eight of the articles were duplicate articles from other search engines and 
closer inspection found that 12 of the articles did not use human subjects.  The remaining articles 
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did not address the research question and were excluded.  A final result of 13 articles were 
included in the critical appraisal grid from this search engine.  The search term used in Pubmed 
was fetal alcohol spectrum disorder with the limiters human subjects and English language had 
an initial yield of 1032 articles.  Through abstract review nine articles were selected for further 
analysis, five were excluded because they did not address the research question.  Four articles 
were included in the appraisal. Google Scholar proved to be a more challenging search tool and 
often resulted in a very high yield with the majority of articles not being pertinent to the 
investigation.  However, using the advanced search option and searching the exact phrase 
physical anomalies and fetal alcohol spectrum disorders together resulted in 153 articles. 
Twenty-one articles from this database were selected for further review, eight fully met the 
research criteria and were used in the critical appraisal of the literature.  
A total of 27 articles addressed the research question and were selected for the critical 
appraisal.  The study methods used included: clinical practice guidelines, review articles, cohort 
studies, prospective studies, retrospective studies, cross-sectional studies, and case-control 
studies.  There were 20 studies that contained level III evidence, three studies with level IV 
evidence, and four studies with level V evidence.  There were six publications from the United 
States including reviews and guidelines and one guideline from Canada.  Study participants 
included participants from the United States, Canada, Italy, South Africa, England, Portugal, 
Russia, Finland, Australia, Spain, Argentina, and Norway.  Studies from the United States 
included Caucasians, Native Americans and Alaska Natives, African Americans, 
Hawaiian/Pacific Islanders, multi-racial participants, and those of Asian descent.  The full 
critical appraisal of each article can be reviewed in the critical appraisal grids (Appendix E). 
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Upon completion of the critical appraisal of current literature, data regarding physical 
anomalies associated with FASD was extracted and combined with data from current guidelines.  
This combined data was used to construct the physical anomaly checklist (Appendix B).  The 
physical anomaly checklist contains 85 physical anomalies.  Only seven of those anomalies are 
included in the diagnostic criteria of FASD.  
Review of current guideline procedures.  The most current guidelines for the diagnosis 
of FASD from the United States, Canada, and other countries were reviewed to combine 
recommendations on differential diagnoses and genetic disorders that should be considered in the 
diagnostic process.  In addition to the CINAHL, Pubmed, Dynamed, Web of Science and Google 
Scholar, The National Guideline Clearing House and the Trip database were used to search for 
current FASD diagnostic guidelines.  The Trip database was used to search for diagnostic 
guidelines from other countries. All guidelines had to be published in English in 2004 to 2015. 
Guideline review findings.  The search for guidelines in CINAHL yielded one article that 
did not address the purpose of this project. Google scholar resulted in five pertinent articles and 
four national guidelines.  The web of science search yielded three articles that did not address the 
project purpose.  The Trip Database was used to search for international guidelines and yielded 
seven pertinent articles.  However, none of the international guidelines addressed specific 
differential diagnoses.  Pubmed resulted in three supportive articles that provided insight into the 
differential diagnoses of FASD.  Dynamed resulted in one guideline that provided information on 
the differential diagnoses of FASD.  The National Guideline Clearing House did not provide any 
pertinent guidelines that addressed the differential diagnoses of FASD.  
The combination of the guidelines and the reference articles resulted in 20 different 
genetic disorder differentials and four exposure related differential diagnoses.  Each diagnosis is 
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identified and the overlapping and distinguishing features are described in the differential 
diagnoses tables (Appendix A).  The differential diagnoses table provides a clinical reference 
tool that supports the providers as they are considering appropriate differentials.  
  Construction of clinical reference tools.  During this phase of the PDSA cycle 
information gathered from the planning phase was used to construct the clinical reference tools. 
The critical appraisal of the literature provided information on the physical anomalies associated 
with prenatal alcohol exposure.  This data was extracted and combined with the data from the 
current guidelines to create a physical anomaly checklist (Appendix B).  The review of the 
guidelines provided information on the differential diagnoses that should be considered during 
the assessment of an individual with suspected FASD.  This information was combined with data 
from supportive articles to generate a table of the differential diagnoses of FASD.  The table 
consists of a list of differentials and highlights the overlapping and distinguishing features of 
each diagnosis (Appendix A). 
Implementation 
Participants 
Project participants consisted of a convenience sample of members of a North American 
FASD medical diagnostic team comprised of nurse practitioners.  In order to participate in the 
post-implementation survey participants had to be responsible for the medical examination of 
children with suspected FASD.  Participants were recruited to participate via email. Initially, all 
five team providers agreed to participate in the educational intervention and review of the 
clinical reference tools.  However, ultimately three of the team providers attended the 
educational presentation and participated in the post-implementation survey.  The participants 
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were all nurse practitioners with a range of clinical experience from six years to 33 years and 
with FASD diagnostic experience from three to 20 years. 
Nurse Practitioner Education 
An educational presentation highlighting the physical anomaly checklist and genetic 
disorder/differentials table was presented to team medical providers.  The education consisted of 
two PowerPoint presentations.  The first presentation provided images and brief case discussion 
of pertinent genetic disorders and exposure syndromes.  The second presentation included 
images of the physical anomalies for each body system.  Images used were cited and covered 
under the one-time use measure as express permission for continued use did not meet project 
time constraints.  
The critical appraisal evidence tables were printed and available for review at the 
educational presentation.  Providers were given copies of the physical exam checklist and genetic 
disorder/differentials table to evaluate.  Questions from providers were addressed following the 
educational presentation and suggestions for formatting changes were discussed as a group. 
Changes to the clinical reference tools were considered based on ease of use in clinical practice. 
Evaluation and Application 
Post Implementation Survey 
  A post-implementation survey was used to collect data from team providers responsible 
for conducting the physical exam portion of the FASD evaluation (Appendix C).  Demographic 
information collected in the post-implementation survey included: number of years in practice, 
the number of years working with the FASD diagnostic team, and type of medical provider.  The 
survey was completed following the provider education and returned to the principle 
investigator.  No personal identifying information was linked directly to the survey. 
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Revision and Application to Practice 
Changes were made to the physical anomaly checklist for ease of use in the practice 
setting based on provider feedback.  After the educational session, clinicians were asked to apply 
the physical assessment template and genetic disorder/syndrome table during FASD evaluations. 
They were given permission to make future changes and to refine the checklist and table to 
continue to meet their practice needs. 
Ethical Concerns 
 A North American FASD diagnostic team received a thorough explanation of how the 
clinical practice improvement project would be carried out.  Written consent was acquired from 
all participating providers (Appendix D).  Each participant was informed that participation was 
voluntary, and that withdrawal from the process could occur at any point.  The participants were 
not subjected to any physical risk.  The confidentiality of the participants was maintained by the 
principle investigator.  All information obtained from the post-implementation surveys and 
signed consent forms are stored in a locked file cabinet in UAA, Health Sciences Building, 
Room 365 for three years after the completion of the study at which time they will be destroyed. 
 The project proposal and methods of this study were approved by the project chair and 
committee member. The project proposal was reviewed by the University of Alaska Anchorage 
(UAA) Institutional Review Board (IRB). The methods met the requirements for the protection 
of human subjects and the project was approved by the UAA IRB with exempt status.  
Results 
The project results include a summary of the data from the post-implementation survey.  
Project outcomes include critical appraisal grids (Appendix E), a physical anomaly checklist 
(Appendix B), and a differential diagnoses table (Appendix A). The physical anomaly checklist 
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and differential diagnoses table were developed for clinical use by a North American FASD 
diagnostic team based on the evidence identified from this project.   
Post-implementation Survey 
 Of the five providers working on the FASD diagnostic team, three providers participated 
in the education and post-implementation survey.  A one and a half hour presentation on physical 
anomalies and the differential diagnoses associated with FASD was provided.  Review of the 
physical anomaly checklist and differential diagnoses table was provided. Following the 
presentation all providers indicated in the survey that they gained information from the 
presentation that will be useful for their practice.  
Providers were asked to circle the malformations they were previously unaware were 
associated with FASD.  A total of 23 of the malformations included in the checklist were 
indicated by one or more of the providers as new information.  However, there was a wide range 
of responses for this question and some providers were more aware of the malformations than 
others.  Due to the small number of participants and in order to protect anonymity the specific 
number of malformations not recognized by each provider will not be addressed.  However, a 
complete list of anomalies some of the providers were unaware of included: low measures of the 
maxillary and mandibular arch, prognathism, accessory tragus, protruding ears, short or webbed 
neck, Klippel-Feil syndrome, intestinal atresia, horseshoe kidney, vesicoureteral reflux, 
radioulnar synostosis, reduced elbow pronation or supination, inability to fully extend fingers, 
overlapping fingers, hypoplastic nails, talipes varus, talipes valgus, brachydactyly, capillary 
hemangioma, naevus flammeus neonatorum, hirsutism, joint contractures and joint laxity.  
 One provider reported never using a checklist for the physical exam, while the other two 
providers reported using a template that did not address all the physical anomalies addressed in 
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the checklist.  All providers reported that they believe the checklist will be easy to use and apply 
to practice.  All providers reported the differential diagnoses table will be helpful in their clinical 
practice.  All providers reported they believe the physical anomaly checklist and differential 
diagnostic table will improve their clinical practice.  One stated I “will keep [the reference tools] 
in [the] exam room and be more thorough.”  
 The only improvement providers wanted to see in the physical anomaly checklist was 
adding a space for written notes.  This change was made and sent back to the team director via 
email.  No additional education was requested by the team.   
Significance to Advanced Nursing Practice 
 Advanced Practice Registered Nurses (APRNs) are charged with providing safe, 
effective, quality care that is evidenced-based (Iglehart, 2013).  In order to improve the quality 
and efficacy of healthcare, evidenced-based frameworks and protocols must be applied to 
clinical practice (Gerrish et al., 2011).  A critical appraisal of the literature and review of 
diagnostic guidelines resulted in 85 physical anomalies that may occur with prenatal alcohol 
exposure and 24 differential diagnoses that should be considered in the diagnostic process.  
These findings are summarized in a physical anomaly checklist and differential diagnoses table 
that may be used as evidenced-based clinical reference tools to help streamline the FASD 
diagnostic process in a North American FASD diagnostic team.  These clinical reference tools 
will address some of the inconsistencies of the guidelines and provide a framework for the 
physical exam.  A thorough physical exam and full consideration of appropriate differentials is 
needed to make a diagnosis of an FASD (Astley, 2004; Chudley et al., 2005).  By providing 
consistent documentation of physical exam findings, advanced practice nurses can play a role in 
determining the full range of effects that may result from prenatal alcohol exposure.  As part of 
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on-going practice improvement, the FASD diagnostic team has been encouraged to continue to 
modify and update the clinical reference tools with new research using the PDSA model to 
ensure that the clinical reference tools continue to be relevant to their clinical practice.  
Recommendations for Future Research 
Recommendations from Providers 
As part of the post-implementation survey providers in the FASD diagnostic team were 
asked to suggest areas of study they believe would be helpful to their practice.  One provider 
reported wanting to see more research on follow-up with families.  Another provider was 
interested in research on the impact that prenatal alcohol exposure has on the next generation’s 
reproductive capacity.  Finally one provider would like see local research on the physical exam 
findings of children with FASD using the physical anomaly checklist.  
Recommendations from the Literature  
There is a need for continued research on the physical anomalies associated with prenatal 
alcohol exposure (Jones et al., 2010).  Large scale cohort studies should be used to develop a 
guideline for the physical evaluation of FASD that is universally recognized by FASD research 
centers on a national level.  Once a nationally recognized standard is in place a study of inter-
rater reliability should be conducted using the standard guideline or checklist to ensure that the 
guideline does indeed produce consistent and reliable findings between examiners.  Finally more 
population based studies should be performed in elementary schools across the United States to 
determine the true prevalence of FASD to help increase public awareness and prevention 
measures (May et al., 2014).  
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Conclusion 
Implementing practice change in a setting where multiple healthcare providers are 
responsible for translating the change into practice can be challenging.  The use of a quality 
improvement model that incorporates feedback from all providers facilitates team participation. 
The PDSA cycle was used as a framework for this project.  This approach not only allowed team 
participation, but also provides a means for ongoing quality improvement and modification of 
the clinical reference tools by the team (Marcellus, Harrison, & Mackinnon, 2012).  Team 
providers can apply the PDSA approach to continue to update and change the physical anomaly 
checklist and differential diagnoses tables to ensure that the team’s approach to assessment is 
evidence-based.  
 The goals of this practice improvement project were to increase provider awareness of 
the physical anomalies associated prenatal alcohol exposure and to increase awareness of the 
differential diagnosis for FASD.  The ultimate purpose of this project is to ensure that the 
physical examination of children with potential FASD is systematic and consistent between team 
providers in a North American FASD diagnostic team.  While achieving this purpose was 
beyond the scope of this project; the team providers may use the clinical reference tools 
produced through this project to study team practices and achieve this goal.   
 Consistent assessment of children with potential FASD and documentation of physical 
anomalies will help to better characterize the potential outcomes of prenatal alcohol exposure 
(Jones et al., 2010).  Furthermore, proper consideration of differential diagnoses is necessary to 
determining an accurate diagnosis and ultimately providing an appropriate treatment plan 
(Astley, 2004).  All healthcare providers responsible for the care of children and their families 
should be aware of the many physical anomalies associated with prenatal alcohol exposure in 
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order to determine when appropriate referral is necessary.  Providers directly participating in 
FASD diagnosis must be aware of the physical anomalies associated with FASD and have a 
working knowledge of potential differential diagnoses (Astley, 2004; Bertrand et al., 2004; 
Chudley et al., 2005; Jones et al., 2010).  The physical anomaly checklist and differential 
diagnoses tables provide team providers the additional information they need to conduct an 
FASD evaluation in a way that is clinically practical utilizing the current evidence available.  
 
 
  
PHYSICAL ASSESSMENT OF FASD                                                                                        31 
References 
Alaska Department of Health and Human Services (2012). Alaska fetal alcohol syndrome  
(FAS) surveillance project. Retrieved from, http://dhss.alaska. gov/dph/wcfh/Pages 
/mchepi/fas/default.aspx 
Astley, S.J. (2004). Diagnostic guide for Fetal Alcohol Spectrum Disorders: The 4-digit  
diagnostic code. Seattle, Washington: University of Washington. 
Astley, S. J. (2014). Twenty years of patient surveys confirm a FASD 4-digit-code   
interdisciplinary diagnosis afforded substantial access to interventions that met patients’ 
needs. J Popul Ther Clin Pharmacol, 21(1), e81-e105 
Autti-Ramo, I., Fagerlund, A., Ervalahti, N., Loimu, L., Korkman, M., & Hoyme, H.E. (2005).  
Fetal alcohol spectrum disorders in Finland: Clinical delineation of 77 older children and 
adolescents. American Journal of Medical Genetics, 140A, 137-143 
Bertrand, J., Floyd, R.L., O’Connor, M.J., Frankel, F., Paley, B., Coles, C.D., Kable, J., Taddeo,  
E., Dent, D., Chasnoff, I., Wells, A., & Bailey (2004). Fetal Alcohol Syndrome: 
Guidelines for Referral and Diagnosis. Fetal Alcohol Spectrum Disorders (FASDs). 
Retrieved from, http://www.cdc.gov/ncbddd/fasd/data.html 
Burd, L., Deal, E., Rios, R., Adickes, E., Wynne, J., & Klug, M. G. (2007). Congenital heart  
defects and fetal alcohol spectrum disorders. Congenital Heart Disease, 2(4), 250-255 
Ceccanti, M., Spagnolo, P. A., Tarani, L., Attilia, M. L., Chessa, L., Mancinelli, R., … &  
Hoyme, H., E. (2007).Clinical delineation of fetal alcohol spectrum disorders (FASD) in  
Italian children: Comparison and contrast with other racial/ethnic groups implications for  
diagnosis and prevention. Neuroscience and Biobehavioral Reviews, 30(2007), 270-277. 
Centers for Disease Control and Prevention (2015). Fetal alcohol spectrum disorders (FASDs).  
PHYSICAL ASSESSMENT OF FASD                                                                                        32 
Retrieved from http://www.cdc.gov/ncbddd/fasd/data.html#ref 
Chudley, A.E., Conry, J., Cook, J. L., Loock, C., Rosales, T., & LeBlanc, N. (2005). Fetal  
alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ, 172(5), S1-S21 
Davis, K., Desrocher, M., & Moore, T. (2011). Fetal alcohol spectrum disorder: A review of  
neurodevelopmental findings and interventions. J Dev Phys Disabil, 23, 141-167. 
Dearholt, S., & Dang, D. (2012). John Hopkins evidence-based practice model and guidelines  
(2nd ed.). Baltimore, MD: Sigma Theta Tau International  
Deroo, L.A., Wilcox, A.J., Drevon, C.A., & Terje Lie, R. (2008). First-trimester maternal alcohol  
consumption and the risk of infant oral clefts in Norway: A population based case-control 
study. American Journal of Epidemiology,168 (6), 638-646  
Douzgou, S., Breen, C., Crow, Y.J., Chandler, K., Metcalfe, K., Jones, E., …Clayton-Smith, J.  
(2012). Diagnosing Fetal alcohol syndrome: New insights from newer genetic 
technologies. Arch Dis Child, 97(9), 812-817 
DynaMed. (2014, November 19). Fetal Alcohol Spectrum Disorder. Ipswich, MA: EBSCO  
Information Services. Retrieved from http://web.a.ebscohost.com.proxy.consor 
tiumlibrary.org /dynamed/detail?vid=2&sid=ddc4ade8-2080-46a0-a83e-
d1ec779f9027%40sessionm gr4001&hid=4114&bdata=JnNpdGU9ZHluYW1lZ 
C1saXZlJnNjb3BlPXNpdGU%3d#db =dme&AN=114397 
Elliot, E.J., Payne, J., Morris, A., Haan, E., Bower, C., & Paediatricians contributing to the  
Australian Paediatric Surveillance Unit. (2008). Fetal alcohol syndrome: A prospective 
national surveillance study. Arch Dis Child, 93, 732-737  
Feldman, H.S., Jones, K.L., Lindsay, S., Slymen, D., Klnoff-Cohen, H., Kao, K, …& Chambers,  
PHYSICAL ASSESSMENT OF FASD                                                                                        33 
C. (2011). Patterns of prenatal alcohol exposure and associated non-characteristic minor 
structural malformations: A prospective study. American Journal of Medical Genetics 
Part A, 155(12), 2949-2955 
Florencia Iveli, M., Morales, S., Rebolledo, A., Savietto, V., Salemme, S., Apezteguia, M., …  
Milesi, V. (2007). Effects of light ethanol consumption during pregnancy: Increased 
frequency of minor anomalies in the newborn and altered contractility of umbilical cord 
artery. Pediatric Research, 61(4), 456-461 
Gerrish, K., Guillaume, L., Kirshbaum, M., McDonnell, Tod, A., & Nolan, M. (2011). Factors  
 Influencing the contribution of advanced practice nurses to promoting evidenced-based  
 practice among front-line nurses: Findings from a cross-sectional survey. Journal of      
Advanced Nursing, 9(1), 1079-1090 
Hoyme, H.E., May, P.A., Kalberg, W.O., Kodituwakku, P., Gossage, J.P., Trujillo, P. M., … &  
Robinson, L.K. (2005). A practical clinical approach to diagnosis of fetal alcohol 
spectrum disorders: Clarification of the 1996 Institute of Medicine Criteria. Pediatrics, 
115(1), 39-47 
Iglehart, J.K. (2013). Expanding the role of advanced nurse practitioners. New England Journal  
 Medicine, 368(20), 1935-1941 
Jones, K.L., Hoyme, H.E., Robinson, L.K., del Campo, M., Manning, M. A., Prewitt, L.M., &  
Chambers, C.D. (2010). Fetal alcohol spectrum disorders: Extending the range of 
structural defects. Am J Med Genet Part A, 152A, 2731-2735 
Jones, K., Smith, D. (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet,  
302(7836), 999-1001 
Kvigne, V. L., Leonardson, G. R., Neff-Smith, M., Brock, E., Borzelleca, J., & Welty, T.K.  
PHYSICAL ASSESSMENT OF FASD                                                                                        34 
(2004). Characteristics of children who have full or incomplete fetal alcohol syndrome. 
The Journal of Pediatrics, 145, 635-640 
Leibson, T., Neuman, G., Chudley, A.E., & Koren, G. (2014). The differential diagnosis of fetal  
alcohol spectrum disorder. J Popul Ther Clin Pharmaco, 21(1), e1-e29 
Manning, M.A., & Hoyme, H. E. (2007). Fetal alcohol spectrum disorders: A practical 
clinical approach to diagnosis. Neuroscience and Behavioral Reviews. 31(2), 230-238 
Marcellus, L., Harrison, A., & MacKinnon, K. (2012). Quality improvement for neonatal nurses,  
Part II: Using a PDSA quality improvement cycle approach to implement an oral feeding 
progression guideline for premature infants. Neonatal Network, 31(4), 215-222 
Martinex-Frias, M., Bermejo, E., Rodriguez-Pinilla, E., & Luis Frias, J. (2004). Risk for  
congenital anomalies associated with different sporadic and daily doses of alcohol 
consumption during pregnancy: A case-control study. Birth Defects Research (Part A),  
70, 194-200 
May, P., Baete, A., Russo, J., Elliot, A. J., Blankenship, J., Kalberg, W.O., … Hoyme, H.E.  
(2014). Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics, 
134(5), 855-866 
May, P.A., Fiorentino, D., Gossage, J.P., Kalberg, W.O., Hoyme, H.E., Robinson, L.K.,  
…Ceccanti, M. (2006). Epidemiology of FASD in a province in Italy: Prevalence and 
characteristics of children in a random sample of schools. Int J Environ Res Public 
Health, 10(4), 1547-1561 
May, P.A., Gossage, J. P., Kalberg, W. O., Robinson, L.K., Buckley, D., Manning, M., &  
Hoyme, E. (2009). Developmental Disabilities Research Reviews, 15(3), 176-192 
Melnyk, B. M. & Fineout-Overholt, E. (2011).  Evidence-based practice in nursing and  
PHYSICAL ASSESSMENT OF FASD                                                                                        35 
healthcare: A guide to best practice (2nd ed.). Philadelphia, PA: Lippincott Williams &     
Wilkins 
Miller, L. C., Chan, W., Litvinova, A., Rubin, A., Comfort, K., Tirella, L., … Boston-Murmansk  
Orphanage Research Team. (2006). Fetal alcohol spectrum disorders in children residing 
in Russian orphanages: A phenotypic survey. Alcoholism Clin Exp Res, 30(3), 531-538 
Murthy, P., Kudlur, S., George, S., & Mathew, G. (2009). A clinical overview of fetal alcohol  
syndrome. Addictive Disorders & Their Treatment, 8(1), 1-11 
O’Leary, C. M., Elliot, E. J., Nassar, N., & Bower, C. (2013). Exploring the potential to use  
daItalta linkage for investigating the relationship between birth defects and prenatal 
alcohol exposure. Birth Defects Research (Part A): Clinical and Molecular Teratology, 
97(7), 497-504 
Ransom, E.R., Maulik, S.J., Nash, D.B., & Ransom, S.B. (2008). The healthcare quality book      
            (2nd ed.). Chicago, IL: Foundation of the American College of Healthcare Executives. 
Ribeiro, I.M., Vale, P.J., Tenedorio, P.A., Rodriguez, P.A., Bilhoto, M.A., & Pereira, H.C.  
(2007). Ocular manifestations in fetal alcohol syndrome, European Journal of 
Opthalmology, 17(1), 104-109 
Sanctis, L., Memo, L., Pichini, S., Tarani, L., & Vagnarelli, F. (2011). Fetal alcohol syndrome:  
new perspectives for an ancient and underestimated problem. The Journal of Maternal-
Fetal and Neonatal Medicine, 24(S1), 34-37 
Senturias, Y., & Asamoah, A. (2014). Fetal alcohol spectrum disorders: Guidance for  
recognition, diagnosis, different, diagnosis, differential diagnosis and referral. Curr Probl 
Pediatr Adolesc Health Care, 44(4), 88-95  
Streissguth, A. P., Bookstein, F. L., Barr, H. M., Sampson, P.D., O’Malley, K., & Young, J. K.  
PHYSICAL ASSESSMENT OF FASD                                                                                        36 
(2004). Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol 
effects. Developmental and Behavioral Pediatrics, 25(4), 228-238 
Stromland, K., Ventura, L.O.,  Mirzaei, L., Fontes de Oliveira, K., Bandim, J. M., Ivo, A.P., &  
Brandt, C. (2014). Fetal Alcohol Spectrum disorders among children in a Brazilian 
Orphanage. Birth defects A: Clinical and molecular teratology, 103(3), 178-185 
Vernescu, R. M., Adams, R.J., & Courage, M. L. (2012). Children with fetal alcohol spectrum  
disorder show and amblyopia-like pattern of vision deficit.  Developmental Medicine & 
Child Neurology, 54(6), 557-562  
Viljoen, D.L., Gossage, J.P., Brooke, L., Adnams, C.M., Jones, K.L., Robinson, L. K., …May,  
P.A. (2005). Fetal alcohol syndrome epidemiology in a South African community: A 
second study of a very high prevalence area. Journal of Studies on Alcohol, 66(5), 593-
604 
Warren, K.R., Hewitt, B.G., & Thomas, J.D. (2011). Fetal alcohol spectrum disorders: Research  
 Challenges and opportunities. Alcohol Research & Health, 34(1), 4-14 
Wattendorf, D.J., & Muenke, M. (2005). Fetal alcohol spectrum disorders. American Family  
Physician, 72(2), 279-285 
 
  
PHYSICAL ASSESSMENT OF FASD                                                                                        37 
Appendix A 
Table 2 
Genetic Disorders Differential Diagnoses  
Genetic disorders Overlapping Features Distinguishing features 
Aarskog syndrome Long and wide philtrum, mid-
face hypoplasia, widely spaced 
eyes, small nose, anteverted 
nares, ADHD with impulsive 
traits. 
Broad Forehead, Rounded 
face, down-slanted palpebral 
fissures, widow’s peak, 
prominent ears, crease below 
lower lip, incomplete out 
folding of upper helices on 
the ears, dental eruption 
problems, hyperextension at 
the proximal interphalangeal 
joints, shawl scrotum, and 
short broad hands, Most have 
normal intellectual capacity, 
x-linked gene FGDI. 
Blepharophimosis 
syndrome 
Short palpebral fissures and 
ptosis.  
Epicanthus inversus, lateral 
displacement of the inner 
canthi with a normal distance 
between pupils, variable 
infertility in females, 
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autosomal dominant trait. 
Molecular defect.  
Bloom Syndrome  Prenatal growth deficiency, 
microcephaly, midface 
hypoplasia, low attention span.  
Narrow long face with 
prominent nose and ears and 
micrognathia, telangiectatic 
skin lesions, café-au-lait 
spots, moderate immune 
deficiency, hypogonadism, 
hypogammaglobulinemia, 
mutations in the BLM gene 
on chromosome 15. 
Brachman-deLange or  
Cornelia deLange  
syndrome 
Long philtrum, thin vermillion 
boarder, microcephaly, 
depressed nasal bridge, 
anteverted nares, upturned 
nose, low IQ, hyperactivity, 
and mid-face hypoplasia 
Single bushy eyebrow 
extending over both eyes, 
long eyelashes, downward 
corners of the mouth, high 
arched palate, low-set 
posteriorly rotated ears, short 
upper limbs, very short 
stature. Molecular defect 
Campomelic Dysplasia Small palpebral fissures Significant skeletal 
abnormalities, significant 
hypotonia, and respiratory 
failure. 
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DiGeorge syndrome Midface hypoplasia, smooth 
philtrum, thin upper lip, 
ADHD 
Hooded eyelid, bulbous nasal  
tip, posteriorly rotated ears, 
microtia, micrognathia, nasal 
dimple 
Dubowitz syndrome Widely spaced eyes, short-
palpebral fissures, Prenatal 
growth deficiency, 
microcephaly, ptosis, 
clinodactyly, developmental 
delay.  
Broad nasal tip, shallow 
supraorbital ridge, infantile 
eczema, cryptorchidism, and 
limb anomalies.  
Duplication 10q Sequence Microcephaly, Short palpebral 
fissures, Growth deficiency, 
Intellectual disability 
 
Bow-shaped mouth, 
Prominent upper lip, High 
forehead, High arched 
eyebrows 
 
Duplication 15q Sequence Small palpebral fissures, short 
philtrum, autistic  behavior 
Intractable epilepsy 
FG syndrome  Thin upper lip, hyperactive 
behavior.  
Macrocephaly, prominent 
forehead, hair whorls or 
upsweep. 
Floating-Harbor Syndrome Smooth philtrum, thin lips. Triangular face with a 
prominent nose and deep-set 
eyes. 
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Geleophysic Dysplasia Flat philtrum and thin upper 
lip. Wide set eyes. 
Full cheeks, delayed bone 
age, cone-shaped epiphyses, 
shortened long tubular bones, 
ovoid vertebral bodies, 
progressive cardiac valvular 
thickening, stenosis of the 
trachea, and respiratory 
insufficiency.  
Miller-Dieker Syndrome Thin upper lip Severe developmental delay, 
epilepsy. 
Noonan syndrome  Low nasal bridge, epicanthal 
folds, wide spaced eyes, and 
long philtrum. 
Palpebral fissures are 
downward slanted, the mouth 
is wide and has a well-formed 
philtrum, protruding upper 
lip, Keratoconus, ptosis of the 
eyes, low nuchal hairline. 
Molecular defect. 
Oculodentodigital 
Syndrome 
Small palpebral fissures. Dental abnormalities: 
microdontia, enamelogenesis 
imperfecta, and missing teeth. 
Opitz Syndrome Smooth philtrum, wide set 
eyes, small palpebral fissures 
Grooving of the nasal tip, 
widow’s peak, cranial 
asymmetry. 
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Other chromosome deletion 
or duplication syndromes 
Often short palpebral fissures, 
mid-facial hypoplasia, and 
smooth philtrum. 
Chromosomal deletion by 
FISH probe analysis. 
Velocardiofacial syndrome Short palpebral fissures, malar 
hypoplasia, microcephaly, and 
learning disabilities. 
Broad nasal root with bulbous 
nasal tip, deficient alae nasi, 
long slender fingers, higher 
prevalence of cardiac defects 
especially conotruncal type. 
Trisomy 18 Small palpebral fissures Prominent occiput, small 
mouth, pointy ears, short 
sternum, flexed fingers, index 
finger overlapping the third 
digit and the fifth digit 
overlapping the fourth digit. 
Williams Syndrome Short palpebral fissures, 
anteverted nares, microcephaly, 
mid-face hypoplasia, long 
philtrum, depressed nasal 
bridge, epicanthal folds, 
microcephaly, low IQ, learning 
disabilities and behavior 
problems. 
 
Wide mouth with full lips, 
stellate pattern of the iris, 
periorbital fullness, broad 
forehead, high round cheeks 
with pointed chin, hoarse 
voice, connective tissue 
disorders, cardiac defects, 
chromosome deletion 
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Table 3 
Exposure related syndromes differential diagnoses  
Disorders related to other 
prenatal exposures  
Overlapping features Distinguishing Features 
   
Fetal Hydantoin  Syndrome Wide-spaced eyes and 
depressed nasal bridge 
Short nose and bowed upper 
lip. 
Fetal Valproate Syndrome Wide-spaced eyes, epicanthal 
folds, anteverted nares, long 
philtrum, and thin vermilion 
border 
High forehead, small mouth, 
infraorbital crease 
Maternal PKU fetal effects Epicanthal folds, short 
palpebral fissures, long 
poorly developed philtrum, 
thin vermillion boarder, 
microcephaly 
Prominent glabella, small up 
turned nose, round face. 
Toluene Embryopathy Short palpebral fissures, mid-
face hypoplasia,  smooth 
philtrum, and thin vermillion 
boarder, microcephaly 
Large anterior fontanel, down 
turned mouth, mandibular 
hypoplasia, abnormal hair 
patterns, and ear 
abnormalities, Toluene 
exposure. 
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(Astley, 2004; Chudley et al., 2005; DynaMed, 2014, November 19; Hoyme et al., 2005; 
Manning & Hoyme, 2007; Bertrand et al., 2004; Leibson, 2014; Senturia & Asamoah, 2014). 
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Appendix B 
Table 4 
Physical Anomaly Checklist 
 
Head + - Notes 
Microcephaly –Head circumference 2SD below 
the mean for age and sex 
   
Persistent patent fontanelles    
Face    
Hypertelorism    
Short palpebral fissure    
Thin vermilion boarder    
Flat philtrum    
Long philtrum    
Facial Asymmetry     
Hypoplastic midface    
Low  measures of the maxillary and mandibular 
arc 
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Flat-nasal bridge    
Micrognathia    
Prognathism    
Eyes    
Epicanthal folds    
Ptosis    
Strabismus    
Decreased visual acuity    
Ears    
Preauricular pit    
Accessory tragus    
Railroad track ear    
Altered shape    
Low-set ears    
Large ear lobes    
Protruding ears    
Asymmetric ears    
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Decreased hearing (Conductive or 
neurosensory) (Confirmed) 
   
Nose    
Short nose    
Anteverted nares    
Mouth    
Cleft lip    
Cleft palate    
High arched palate    
Dental crowding     
Neck    
Short or webbed neck    
Klippel-Feil syndrome    
Chest    
Pectus Excavatum    
Pectus Carinatum    
Cardiovascular    
Murmur    
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Congenital cardiac defect (Confirmed) 
[ASD, VSD, aberrant great vessels, tetralogy of 
fallot, conotruncal heart defects (truncus 
arteriosus, tetralogy of the fallot, interrupted 
aortic arch, double outlet right or left ventricle, 
transposition of the arteries)]. 
   
Abdomen (GI)    
Intestinal atresia (confirmed)    
Renal     
Aplastic/dysplastic/Hypoplastic kidneys 
(Confirmed) 
   
Horseshoe kidney (Confirmed) 
 
   
Ureteral duplications (Confirmed) 
 
   
Hydronephrosis (Confirmed) 
 
   
Vesicoureteric reflux (Confirmed) 
 
   
Back    
Scoliosis    
Spina bifida (confirmed)    
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Thoracic kyphosis    
Hemivertibrae (confirmed)    
Cervical rib (confirmed)    
Arms    
Radioulnar synostosis     
Reduced elbow pronation or supination    
Hands    
Hockey stick palmar crease    
Abnormal palmar crease    
Clinodactyly    
Camptodactyly    
Brachydactyly    
Shortened fifth digits    
Inability to fully extend fingers    
Overlapping fingers    
Hypoplastic nails    
Feet    
Talipes varus    
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Talipes valgus    
Brachydactyly     
Clinodactyly    
Camptodactyly    
Skin    
Capillary hemangioma    
Naevus flammeus neonatorum    
Hirsutism     
Neurologic    
Poor tandem gate    
Poor hand eye coordination    
Neurosensory hearing loss (confirmed)    
Nystagmus    
Impaired fine motor skills    
Memory problems    
Meningomyelocele (confirmed)    
Hydrocephalus (confirmed)    
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Partial or complete agenesis of the corpus 
callosum (confirmed) 
Joints    
Contractures    
Laxity    
Other Musculoskeletal    
Hypotonia    
 
Confirmed: History of diagnoses, or diagnoses made with testing beyond the physical exam 
 
Other Anomalies:______________________________________________________________ 
____________________________________________________________________________ 
____________________________________________________________________________ 
____________________________________________________________________________ 
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Appendix C 
Post Implementation Survey 
Physical Assessment of children with FASD: Evidence-Based Practice 
Demographic information: 
1.) Number of years in clinical practice at your current level of training: 
2.) Type of provider: 
3.) How long have you worked with an FASD diagnostic team: 
__________________________________________________________________ 
1. Have you gained information on malformations related to prenatal alcohol exposure that 
you did not know prior to this intervention?  
 
2. If so, please list any malformations that you were not previously aware of.  
 
3. Have you used a physical exam template prior to using the research template? If so how 
was it different than the research template? 
 
4. Do you find the template and reference table easy to understand and do you believe it will 
be simple to implement into practice? 
 
 
5. Do you believe that the physical exam template and genetic disorder table will improve 
your clinical practice?  Please explain: 
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6. What changes could be made to template and reference tables to make them easier to 
use? 
 
7. Would you like anymore education on the use of the template and diagnostic table? 
Please specify areas of education: 
 
8. What clinical questions would you like to see investigated regarding FASD diagnosis in 
the future? 
 
9. Is there any other information you would find helpful in your diagnosis of children with 
FASD? 
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Appendix D 
 
Consent Form 
 
Physical Assessment of children with FASD: Evidence-Based Practice 
 
Principal investor: 
Tabitha Waller, Family Nurse Practitioner Student, University of Alaska Anchorage 
Email: tmwaller@alaska.edu               Phone: (907)-720-9792 
 
DESCRIPTION:  
The purpose of this study is to review current literature and guidelines regarding the physical anomalies associated 
with FASD and genetic syndromes that should be considered in the differential diagnoses. Based on the evidence a 
physical exam template and genetic/ differentials table with distinguishing characteristics will be created. Education 
on these resources will be presented and copies will be given to participants. All participants will be asked to apply 
these resources to their clinical practice. The participants will also asked to complete a post implementation survey. 
Surveys will be collected following the educational intervention.  
 
VOLUNTARY NATURE OF PARTICIPATION: 
Participation in this study is voluntary. If you do not want to participate, or want to stop your participation at any 
time during this study, you will not be penalized.  
 
CONFIDENTIALITY: 
Your name or contact information will not be connected to your responses. Any documentation that includes name 
such as this consent form will be kept in a secured file cabinet and will only be accessible by me. Any publication of 
this study will not provide any identifying information. Direct quotes may be used but your identifiable information 
will not be linked to quotations or summaries of the data you provide. 
 
BENEFITS: 
There is no direct benefit to you from the participation in this study. The information obtained for the study will be 
used to benefit health care providers responsible for the medical assessment of children with suspected FASD. 
 
RISKS: 
There are no known risks associated with your participation. 
 
CONTACTS: 
If you have any questions about this research, please contact the principal investigator with the phone number or 
email listed above. If you have any further questions regarding your rights as a research participant, please contact 
Dr. Lisa Jackson, study chair, at (907)-786-4590 
 
SIGNATURE: 
Your signature indicates that you fully understand the above study, what is being asked of you, and your signing is 
of your own free will. 
Signature:__________________________________         Date:________________ 
Printed Name:________________________________ 
 
You may have a copy of this consent form 
 
